GlycoMimetics (GLYC) Financials

$14.62

$-1.08 (-6.88%)

As on 18-Jun-2025 09:30EDT

Market cap

$10 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

300.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	0.05	--	0.01	0.07	1.16	10.16
Cost of Revenue	0.04	0.04	0.15	1.03	1.01	--
Gross Profit	0.01	--	0.01	0.07	1.16	10.16
Operating Expenses	31.32	40.04	39.29	47.48	64.61	61.67
Operating Profit (EBIT)	-31.32	-32.51	-39.28	-47.40	-63.45	-51.51
Other Income	--	--	--	--	--	--
Profit before Tax	-29.49	-37.88	-36.90	-46.69	-63.43	-51.03
Provision for Tax	0.03	--	0.00	46.64	-0.28	-0.75
Profit after Tax (Net Income)	-29.49	-37.88	-36.90	-93.33	-63.14	-50.27
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-46.69	-63.43	-51.03

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	3,375.25	5,313.56	38.41	42.93	81.60	128.22
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	0.07	1.89	0.92	2.18
Current Liabilities	2,616.93	5,777.89	6.84	8.88	11.82	12.43
Total Liabilities	8,609.11	11.09	45.32	51.81	94.35	142.83

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	--	--	1.53	1.10	4.09	4.56
Current Assets	5,992.18	11.09	43.79	50.71	90.26	138.27
Total Assets	11,980.98	11.09	45.32	51.81	94.35	142.83
Total Debt*	--	66.84	0.81	0.92	1.92	2.82
Net Current Assets	3.38	5.31	36.96	41.83	78.96	125.84

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-31.10	-34.88	-46.46	-57.49	-39.24
Cash Flow from Investing Activities	--	--	--	-0.08	-0.01	-0.07
Cash from Financing Activities	--	0.01	28.82	4.16	10.72	18.14
Net Cash Inflow / Outflow	--	--	--	--	--	-21.17

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-1.40	-88.84	-146.54	-58.86	-34.81
ROE (%)	-1.74	-1.42	-90.72	-149.88	-60.19	-35.60
ROA (%)	-0.49	-134.30	-75.98	-127.71	-53.24	-32.35
EBIT Margin (%)	-39,489.19	--	-392,746.56	-63,267.27	-5,469.57	-506.83
Net Margin (%)	-54,517.30	--	-368,994.20	-124,562.69	-5,443.31	-494.68
Cash Profit Margin (%)	-2.65	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	440.86	-1.00	-0.87	-0.94	-0.89	0.13
EBIT Growth (%)	45.86	3.55	17.15	25.29	-23.18	16.09
Net Profit Growth (%)	20.90	-2.66	60.46	-47.81	-25.60	7.10
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	--	--	--	--	--
Price / Book Value	300.17	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.48	281.51	1.05	0.99	1.40	2.62
Close Price ($)	21.00	24.90	236.00	303.00	144.00	376.00
High Price ($)	316.00	352.99	416.00	319.20	440.00	550.00
Low Price ($)	14.06	14.06	111.00	51.00	141.00	182.00
Market Cap ($ Cr)	10.13	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	0.01	0.02	0.02	0.02	0.02
Short term debt to equity ratio	--	0.01	0.02	0.02	0.01	0.01
Current Ratio	2.29	0.00	6.41	5.71	7.63	11.13
Quick Ratio	2.29	--	--	5.73	52.78	110.66
Interest Coverage	--	--	--	-1.02	-3,140.16	--

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	--	1,758.20	192.21	0.12	0.02
Asset Turnover	0.00	--	0.00	0.00	0.01	0.07
Receivable days	--	--	5,841.00	354.31	0.55	3.38
Inventory Days	--	--	-344.04	-94,474.65	-319,058.45	--
Payable days	--	6,217.05	2,189.94	544.57	756.26	--
Cash Conversion Cycle	--	--	3,307.03	-94,664.91	-319,814.17	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.